Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAG vs GSK✓SelectedUSD · GSKCAG vs GSK performance historyLatest closeAs of+1.09%11/18
Stock and ETF performance explorer

CAG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.8%
GSK return
+7.0%
Excess return
-15.8%
Maximum drawdown
-35.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-1.3%+2.4%+1.6%
7D0.0%-3.1%+3.1%+1.2%
30D+6.9%-0.9%+7.8%+7.4%
3M-3.3%-4.2%+0.8%-2.2%
6M+10.0%-1.6%+11.6%+10.5%
YTD-8.4%+2.6%-11.0%-11.6%
All-8.8%+7.0%-15.8%-13.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling